Prof. Paul Scherz argues that AI-driven precision medicine and genetic risk prediction can undermine human dignity by turning health into an endless management of risk, increasing anxiety, weakening prudence, and subordinating both patients and clinicians to institutional control.

This lecture was given on March 26th, 2026, at New York University.

For more information on upcoming events, visit us at thomisticinstitute.org/upcoming-events.

About the Speakers:

Paul Scherz is the Our Lady of Guadalupe Professor of Theology. His work examines the intersection of theology, science, medicine, and technology. His interests in ethics center on the role of virtue ethics, especially Stoic virtue ethics, in moral theology. He has published articles on many topics in bioethics, such as human enhancement, genetic technology, and end of life ethics. His books analyze issues like the moral formation of scientists, the role of risk in contemporary practical reason, the ethics of precision medicine, and the ethics of artificial intelligence.

He began his career in science with a BA in molecular and cell biology from UC Berkeley (2001), a PhD in genetics from Harvard (2005), and a postdoctoral fellowship at UCSF. He then received an MTS and a PhD in moral theology from the University of Notre Dame (2010, 2014). His previous teaching positions were at the Catholic University of America and the University of Virginia. He is currently working on projects on the ethics of artificial intelligence and the historical influence of Stoicism on moral theology.

Keywords: AI, Automation Bias, Clinical Judgment, Dignity, Explainable AI, Genetic Risk, Precision Medicine, Prudence, Risk Reduction, Surveillance Capitalism